AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo

Byung Hyun Cha (Creator)
Minjin Jung (Creator)
Angela S. Kim (Creator)
Victoria C. Lepak (Creator)
Brett Colson (Creator)
David A Bull (Creator)
Youngwook Won (Creator)
Byung Hyun Cha (Creator)

Dataset

Description

Abstract Cardiac hypertrophy is one of the most common genetic heart disorders and considered a risk factor for cardiac morbidity and mortality. The mammalian target of rapamycin (mTOR) pathway plays a key regulatory function in cardiovascular physiolog...

Date made available	2021
Publisher	figshare

DOI
10.6084/m9.figshare.c.5673676.v1

Access Dataset

Creative Commons Attribution 4.0 International

1 Article

AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo
Cha, B. H., Jung, M., Kim, A. S., Lepak, V. C., Colson, B. A., Bull, D. A. & Won, Y., Dec 2021, In: Journal of Biological Engineering. 15, 1, 24.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations

AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo

Description

DOI

Access Dataset

Research output

AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo

Cite this